Zoom's Stake in Anthropic Valued at $3.13 Billion

By: www.theblockbeats.info|2026/08/27 01:19:31

Zoom expects its adjusted earnings per share for the third quarter to be between $1.46 and $1.48, falling short of analysts' average expectation of $1.50, indicating the impact of competition in the video conferencing market on profitability. Following the earnings report, Zoom's stock price fell by 3.8% in after-hours trading. The company anticipates third-quarter revenue to be between $1.275 billion and $1.28 billion, while analysts expect an average of $1.28 billion. Zoom has introduced new features such as the AI Companion assistant to attract users, but faces fierce competition from Microsoft Teams and Google Meet. The value of Zoom's stake in Anthropic has increased to $3.13 billion, resulting in a paper gain of $1.61 billion. Zoom invested in Anthropic at the beginning of 2023 and established a partnership to integrate the Claude model into Zoom products. In July of this year, Zoom made an additional investment of $301 million in Anthropic.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

You may also like

X to Implement 'Gateway' to Cryptocurrency Trading, Possibly Connecting to External Services via Cashtags

In the Era of Tool Equality, Retail Investors Are Using Wall Street's Execution Methods and Complex Tools

Three Years, One World: How WEEX Built a Global Legacy on the Way to TOKEN2049 Singapore

In October, WEEX returns to TOKEN2049 Singapore for the third year running and the second time as a Platinum Sponsor. It is a milestone worth pausing on — not because sponsorship titles are rare in this industry, but because so few exchanges have earned the right to say they showed up, year after year, through every version of this market.

FDA approves Rasonque, the first oral therapy targeting the RAS pathway in pancreatic cancer

The FDA has approved Rasonque, a daily pill from Revolution Medicines for adults with previously treated metastatic pancreatic cancer. The drug showed a median survival of 13.2 months compared to 6.7 months with chemotherapy, although its list price amounts to USD $39,800 for a 30-day supply.

[Tax Gaps] ① Unclear Tax Basis for Infinite Futures of Overseas Virtual Assets

The implementation of taxation on digital assets (virtual assets) is just four months away. The taxation on digital assets is set to take effect on January 1, 2027, with a basic deduction of 2.5 million KRW and a tax rate of 20% (up to 22% including local taxes). One of the shortcomings pointed out ...

Japanese Government and Bank of Japan to Develop Blockchain Infrastructure for 24-Hour Settlement of Stocks and Bonds

...

Latest coin listings on WEEX

iconiconiconiconiconiconicon
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com